Kwality Pharmaceuticals Limited (BOM:539997)

Kwality Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 22, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	11,516	9,017	4,248	3,191	6,018	581
Market Cap Growth	22.99%	112.27%	33.12%	-46.97%	935.71%	119.18%
Enterprise Value	12,263	9,948	5,076	4,145	6,180	772
Last Close Price	1109.85	869.05	409.40	307.55	580.00	56.00
PE Ratio	23.46	22.63	17.85	16.47	5.02	3.84
PS Ratio	2.72	2.44	1.38	1.27	1.32	0.22
PB Ratio	3.99	3.44	1.91	1.60	3.35	0.97
P/TBV Ratio	3.99	3.44	1.90	1.59	3.32	0.95
P/FCF Ratio	31.17	30.65	32.33	-	110.54	17.58
P/OCF Ratio	18.55	17.11	9.88	7.71	9.93	2.18
EV/Sales Ratio	2.90	2.69	1.65	1.65	1.36	0.29
EV/EBITDA Ratio	12.86	12.13	7.46	6.73	3.56	2.56
EV/EBIT Ratio	16.14	15.61	10.48	8.88	3.80	3.26
EV/FCF Ratio	33.20	33.81	38.62	-	113.51	23.35
Debt / Equity Ratio	0.38	0.43	0.44	0.45	0.35	0.69
Debt / EBITDA Ratio	1.16	1.37	1.44	1.46	0.36	1.37
Debt / FCF Ratio	2.99	3.82	7.47	-	11.61	12.47
Asset Turnover	0.97	0.88	0.82	0.72	1.80	1.76
Inventory Turnover	2.61	2.33	1.92	1.63	4.88	5.75
Quick Ratio	1.23	1.07	0.90	0.68	0.65	0.59
Current Ratio	1.88	1.67	1.60	1.65	1.63	1.35
Return on Equity (ROE)	18.58%	16.41%	11.20%	10.18%	100.10%	28.41%
Return on Assets (ROA)	10.90%	9.47%	8.10%	8.40%	40.13%	9.90%
Return on Invested Capital (ROIC)	15.59%	13.89%	12.33%	13.75%	75.28%	19.99%
Return on Capital Employed (ROCE)	24.70%	23.00%	20.00%	20.50%	80.90%	26.90%
Earnings Yield	4.26%	4.42%	5.60%	6.07%	19.94%	26.07%
FCF Yield	3.21%	3.26%	3.09%	-1.97%	0.91%	5.69%
Buyback Yield / Dilution	-0.01%	-	-	-	-0.00%	-
Total Shareholder Return	-0.01%	-	-	-	-0.00%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.